Personalized Screening for Kidney Disease Evaluated in T1DM
THURSDAY, Nov. 10, 2022 (HealthDay News) — For persons with type 1 diabetes, a personalized alternative to annual urinary albumin screening can reduce the time spent with undetected kidney disease, according to a study published online Nov. 2 in Diab…
Learn MoreRisk for Advanced Fibrosis Examined for Relatives of NAFLD Patients
THURSDAY, Nov. 10, 2022 (HealthDay News) — The risk for advanced fibrosis is increased for first-degree relatives of probands with nonalcoholic fatty liver disease (NAFLD) with advanced fibrosis, according to a study published online Nov. 1 in the Jo…
Learn MoreLas olas de calor sin aire acondicionado son una combinación letal en las cárceles de Texas
MARTES, 8 de noviembre de 2022 (HealthDay News) — Las olas de calor podrían estar acabando con las vidas de los prisioneros de Texas, según un análisis, que encontró unas tasas de mortalidad superiores a las normales en las prisiones del estado, que …
Learn MoreOptions Explored for MM That Relapses After BCMA CAR T Therapy
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Patients with multiple myeloma that relapses after B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell (CAR T) therapy can potentially be treated with multiple lines of salvage therapy…
Learn MoreASN: Empagliflozin Cuts Risk for Progression in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with chronic kidney disease at risk for progression, the risk for progression of kidney disease or death from cardiovascular causes is reduced with empagliflozin treatment, according to a study …
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — For patients with advanced and progressive chronic kidney disease, discontinuation of treatment with renin-angiotensin system (RAS) inhibitors is not associated with a difference in the long-term rate of dec…
Learn MoreLeg Artery Disease Can Lead to Amputation, But a Surgery May Help Prevent That
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Doctors know a lot about the best ways to treat heart attacks and strokes, but until now they really didn’t have this kind of information for peripheral artery disease (PAD).Affecting as many as 10 million p…
Learn MoreKidney Disease Is Tougher on Men Than Women, and Researchers Now Know Why
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Women tend to be better able than men to recover from kidney injury, but why?Apparently women have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidn…
Learn MoreAHA: Strategies Compared for Treating Chronic Limb-Threatening Ischemia
TUESDAY, Nov. 8, 2022 (HealthDay News) — For patients with chronic limb-threatening ischemia (CLTI), an initial strategy of surgical revascularization is better than endovascular therapy for those with a single segment of great saphenous vein that co…
Learn More